Skip to main content

Featured

Five Key Tax Changes Coming in 2026: What Canadians Need to Know

  As 2026 approaches, Canadians can expect several important updates to the federal tax system. These changes affect retirement planning, income tax brackets, and a range of credits that influence how much individuals and families will owe—or save—when filing their returns. Here’s a quick look at five of the most notable adjustments. 1. Higher RRSP Contribution Limits Canadians will be able to contribute more to their Registered Retirement Savings Plans (RRSPs) in 2026, thanks to inflation indexing. The increased limit gives savers more room to reduce taxable income while building long‑term retirement security. 2. Updated Federal Tax Brackets Income tax brackets will shift upward to reflect inflation. This means more of your income will be taxed at lower rates, helping offset rising living costs and preventing “bracket creep,” where inflation pushes taxpayers into higher tax brackets without real income gains. 3. Increased Basic Personal Amount (BPA) The Basic Personal Amoun...

article

Drug shortages in Canada affect millions of patients and health care providers

 

  

Many Canadians have experienced the frustration and anxiety of not being able to get the medications they need, as the country faces a persistent and worsening problem of drug shortages.

According to a survey commissioned by the Canadian Pharmacists Association, one in four adults in Canada has either personally been affected by drug shortages in the last three years or knows someone who has. The survey also found that 70% of pharmacists have difficulty finding alternative drugs for their patients.

The causes of drug shortages are complex and varied, ranging from manufacturing issues, supply chain disruptions, regulatory hurdles, market decisions by pharmaceutical companies, and increased demand for certain drugs due to the COVID-19 pandemic.

Some of the drugs that have been in short supply include Lenoltec No. 4, a painkiller containing codeine; Ozempic, a widely-used drug for type 2 diabetes; EpiPens, which are essential for people with life-threatening allergies; Wellbutrin, a popular antidepressant; and various blood pressure medications.

Drug shortages can have serious consequences for patients and health care providers, such as increased costs, reduced quality of care, delayed or cancelled treatments, adverse reactions, medication errors, and psychological distress.

Health Canada has said it is aware of the issue and working to find solutions, such as facilitating the importation of foreign drugs, monitoring the supply situation, and collaborating with stakeholders. However, some experts have called for more action, such as investing in domestic production capacity, creating a national drug agency, and implementing mandatory reporting of drug shortages by manufacturers.

Comments